Bioventus Inc.

BVS Nasdaq CIK: 0001665988

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
Phone (919) 474-6700
Fiscal Year End 1231
EIN 810980861

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 24, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 13, 2026 View on SEC
10-K Annual financial report March 5, 2026 View on SEC
8-K Current report of material events March 5, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC

Annual Reports

10-K March 5, 2026
  • Strategic pivot to core, higher-growth areas: orthobiologics, pain management, and restorative treatments.
  • Strong Adjusted EBITDA of $80 million, indicating underlying operational strength despite a net loss.
View Analysis

Insider Trading

SELL 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.